Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine conditions affecting hundreds of millions of women globally. The former name polycystic ovary syndrome (PCOS) was inaccurate, underpinning the robust nomenclature change process. This review historically traces renaming efforts up to, i...
H. Teede, Saeede Saadati, Rachel Morman et al.· Fertility and Sterility· 0 citations
Recognizing PMOS as an early-life marker of cardiometabolic disease highlights opportunities for earlier diagnosis, prevention, and individualized risk stratification, supporting integrated, patient-centered care across the life course.
M. Forslund, J. Melin, A. Joham et al.· Journal of Internal Medicine· 0 citations
This population-based study aimed to characterize the distribution of inter-rectus distance (IRD) and its upper range in adult women using standardized multisite ultrasound measurements and a percentile-based interpretive framework. Data was driven from the Finnish Women’s Health Study (WENDY, 2020–2023), comprising wo...
Annu Marttila, Katariina Kilpivaara, J. Kinnunen et al.· Hernia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.